RNA therapeutics for neurological diseases
British Medical Bulletin · 12.09.2023 · 147 (1) · 50-61
DOI: 10.1093/bmb/ldad010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Medical Bulletin, online erschienen am 20.05.2023. Verfasst von Ilaria Brentari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Biologia Cellulare, Computazionale e Integrata (CIBIO), Università degli Studi di Trento, 38123 Trento, Italy. Hauptthemen laut MEDLINE: RNA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Introduction Ribonucleic acid (RNA) therapeutics are a new class of drugs whose importance is highlighted by the growing number of molecules in the clinic. Sources of data We focus on RNA therapeutics for neurogenetic disorders, which are broadly defined as diseases with a genetic background and with at least one clinical sign affecting the nervous system. A systematic search identified 14 RNA drugs approved by FDA and many others in development. Areas of agreement The field of RNA therapeutics is changing the therapeutic scenario across many disorders. Areas of controversy Despite its recent successes, RNA therapeutics encountered several hurdles and some clinical failures. Delivery to the brain represents the biggest challenge. Growing points The many advantages of RNA drugs make the development of these technologies a worthwhile investment. Areas timely for developing research Clinical failures stress the importance of implementing clinical trial design and optimizing RNA molecules to hold the promise of revolutionizing the treatment of human diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Biologia Cellulare, Computazionale e Integrata (CIBIO), Università degli Studi di Trento, 38123 Trento, Italy.
- Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
- Medical Genetics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.
Zitieren
APA
Brentari, I., Zadorozhna, M., Denti, M. A., & Giorgio, E. (2023). RNA therapeutics for neurological diseases. British Medical Bulletin, 147(1), 50-61. https://doi.org/10.1093/bmb/ldad010
Vancouver
Brentari I, Zadorozhna M, Denti MA, Giorgio E. RNA therapeutics for neurological diseases. British Medical Bulletin. 2023;147(1):50-61. doi:10.1093/bmb/ldad010
BibTeX
@article{Brentari2023,
author = {Brentari, Ilaria and Zadorozhna, Mariia and Denti, Michela Alessandra and Giorgio, Elisa},
title = {RNA therapeutics for neurological diseases},
journal = {British Medical Bulletin},
year = {2023},
volume = {147},
number = {1},
pages = {50--61},
doi = {10.1093/bmb/ldad010}
}
EUVIMED